Izokibep Improves Multiple PsA Symptoms in Phase 2 Study - Medscape

Retrieved on: 2022-06-07 15:43:04

Tags for this article:

Click the tags to see associated articles and topics

Izokibep Improves Multiple PsA Symptoms in Phase 2 Study - Medscape. View article details on hiswai:

Excerpt

Izokibep is an antibody mimetic that inhibits IL-17A designed to “overcome the limitations of monoclonal antibodies,” according to its developers.

Article found on: www.medscape.com